Edible Yellow Mealworm-Derived Antidiabetic Peptides: Dual Modulation of α-Glucosidase and Dipeptidyl-Peptidase IV Inhibition Revealed by Integrated Proteomics, Bioassays, and Molecular Docking Analysis
Yuying Zhu, Enning Zhou, Yingran Tang, Qiangqiang Li, Liming Wu · 2025
Read Edible Yellow Mealworm-Derived Antidiabetic Peptides: Dual Modulation of α-Glucosidase and Dipeptidyl-Peptidase IV Inhibition Revealed by Integrated Proteomics, Bioassays, and Molecular Docking Analysis by Yuying Zhu, Enning Zhou, Yingran Tang, Qiangqiang Li, Liming Wu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12785325.txt.
Description
Mealworms may seem an unlikely source of diabetes drugs, but Yuying Zhu and co-authors mined the yellow mealworm Tenebrio molitor for peptides that fight type 2 diabetes on two fronts. Guided by proteomics, their screening found six peptides that block two enzymes at once: alpha-glucosidase and dipeptidyl-peptidase IV. The peptides also raised glucose uptake in insulin-resistant liver cells.
Docking maps show how the peptides grip each enzyme's active sites through hydrogen bonds and hydrophobic contacts. The team frames insect protein as both a sustainable food resource and a source of candidate therapies. Lab tests so far are early, and animal or human studies would come next.
Catalog record
| CREATOR | Yuying Zhu, Enning Zhou, Yingran Tang, Qiangqiang Li, Liming Wu |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |